On Friday, the Swiss market concluded trading on a positive note, mirroring gains seen across European markets as investors diversified their portfolios by acquiring shares across multiple sectors. The Swiss Market Index (SMI) rose by 101.06 points, or 0.88%, closing at 11,589.34, just shy of the session's peak of 11,597.29.
UBS Group saw a rise of 2.14%, while stocks such as Julius Baer, Lindt & Sprüngli, Novartis, Partners Group, Kuehne + Nagel, Swatch Group, SIG Group, Lonza Group, Logitech International, and Swiss Re experienced increases ranging from 1% to 1.53%.
Companies including Geberit, Richemont, Alcon, Adecco, Givaudan, Schindler Paralleled Shares, and ABB advanced between 0.7% and 1%. Straumann Holding, Sika, Nestlé, and Swisscom also ended the day with modest gains.
ams OSRAM AG soared by 5.3%, while Galderma increased by approximately 2.3%. Other firms such as Galenica Santé, Roche Holding, Swiss Prime Site, Georg Fischer, PSP Swiss Property, Temenos Group, and BKW marked their sessions with strong finishes.
A standout performance came from Relief Therapeutics, with shares surging over 8%, driven by a positive announcement regarding its anticipated definitive agreement for a potential reverse merger with the U.S.-based company Renexxion, expected in the first quarter of 2025.